A randomized controlled trial to compare the safety and effectiveness of doxycycline (200 mg daily) with oral prednisolone (0·5 mg kg−1 daily) for initial treatment of bullous pemphigoid: a protocol for the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) Trial

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 173, Iss. 1, 2015-07 ,pp. : 227-234

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ciclosporin compared with prednisolone therapy for patients with pyoderma gangrenosum: cost‐effectiveness analysis of the STOP GAP trial

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 177, Iss. 6, 2017-12 ,pp. : 1527-1536

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety gains don't translate into reduced costs or increased QALYs for doxycycline compared with prednisolone for patients with bullous pemphigoid

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 178, Iss. 2, 2018-02 ,pp. : 320-321

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effectiveness and Cost-Effectiveness of Dialectical Behaviour Therapy for Self-Harming Patients with Personality Disorder: A Pragmatic Randomised Controlled Trial

By  

Psychotherapy and Psychosomatics, Vol. 81, Iss. 6, 2012-09 ,pp. : 356-365

Karger

Access to resources Recommend Favorite

Cost-Effectiveness of Posaconazole Compared with Standard Azole Therapy for Prevention of Invasive Fungal Infections in Patients at High Risk in Switzerland

By  

Oncology, Vol. 78, Iss. 3-4, 2010-04 ,pp. : 172-180

Karger

Access to resources Recommend Favorite